Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib

June 2019

Antithrombotic combos for patients with atrial fib PLUS a coronary stent are a moving target...due to evolving evidence and stent technology.

The standard used to be "triple therapy"...an anticoagulant (warfarin, etc) plus TWO antiplatelets (aspirin and clopidogrel, etc).

Expect a shift toward DUAL therapy at discharge. Most atrial fib patients will get TRIPLE therapy right after stent placement.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Ulcerative Colitis Update Your Acute Ulcerative Colitis Protocols With the Latest Evidence
Sepsis Weigh Options When Choosing Pressors for Septic Shock
Antithrombotics Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib
Pregnancy Expedite Treatment for Women With Severe Gestational Hypertension
Cannabinoids Be Prepared With Answers About CBD
Migraine Lean Toward Prochlorperazine for Acute Pediatric Migraines
Opioids Facilitate Opioid Tapers During Transitions of Care
Parkinson's Disease Properly Manage the New Inhaled Levodopa (Inbrija) on Admission
Insomnia Explain Risk of Strange Sleep Behaviors With "Z-Drugs"